Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 22, 2024

BUY
$191.17 - $325.63 $277,770 - $473,140
1,453 Added 8.58%
18,391 $5.99 Million
Q4 2023

Jan 16, 2024

BUY
$160.99 - $215.69 $238,748 - $319,868
1,483 Added 9.6%
16,938 $3.23 Million
Q3 2023

Oct 24, 2023

BUY
$194.33 - $283.97 $289,551 - $423,115
1,490 Added 10.67%
15,455 $3.08 Million
Q2 2023

Jul 25, 2023

BUY
$223.05 - $302.68 $615,171 - $834,791
2,758 Added 24.61%
13,965 $3.99 Million
Q1 2023

Apr 14, 2023

BUY
$175.41 - $217.92 $1.24 Million - $1.54 Million
7,070 Added 170.9%
11,207 $2.43 Million
Q4 2022

Feb 08, 2023

BUY
$204.38 - $296.82 $508,293 - $738,191
2,487 Added 150.73%
4,137 $850,000
Q3 2022

Oct 25, 2022

BUY
$195.21 - $310.53 $91,553 - $145,638
469 Added 39.71%
1,650 $459,000
Q2 2022

Aug 12, 2022

SELL
$115.91 - $214.48 $347 - $643
-3 Reduced 0.25%
1,181 $226,000
Q1 2022

May 11, 2022

BUY
$127.96 - $207.36 $2,431 - $3,939
19 Added 1.63%
1,184 $246,000
Q4 2021

Feb 08, 2022

BUY
$165.13 - $241.83 $25,099 - $36,758
152 Added 15.0%
1,165 $208,000
Q3 2021

Nov 02, 2021

SELL
$163.99 - $235.57 $338,311 - $485,980
-2,063 Reduced 67.07%
1,013 $209,000
Q2 2021

Aug 11, 2021

SELL
$131.45 - $201.49 $8,675 - $13,298
-66 Reduced 2.1%
3,076 $584,000
Q1 2021

May 14, 2021

SELL
$92.73 - $142.05 $38,019 - $58,240
-410 Reduced 11.54%
3,142 $409,000
Q4 2020

Feb 12, 2021

BUY
$67.44 - $103.72 $2,495 - $3,837
37 Added 1.05%
3,552 $368,000
Q3 2020

Nov 04, 2020

BUY
$42.79 - $75.8 $150,406 - $266,437
3,515 New
3,515 $266,000
Q3 2019

Nov 07, 2019

SELL
$29.71 - $55.23 $121,127 - $225,172
-4,077 Closed
0 $0
Q2 2019

Aug 06, 2019

BUY
$29.73 - $66.02 $121,209 - $269,163
4,077 New
4,077 $233,000

Others Institutions Holding SWAV

About Shockwave Medical, Inc.


  • Ticker SWAV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 35,927,100
  • Description
  • ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease ...
More about SWAV
Track This Portfolio

Track Raymond James Financial Services Advisors, Inc. Portfolio

Follow Raymond James Financial Services Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James Financial Services Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Raymond James Financial Services Advisors, Inc. with notifications on news.